Search Tag: abioSCOPE

ICU Management

2025 14 Oct

  Biomarkers are essential tools in the emergency department for improving early detection, risk stratification, and patient management. This article reviews challenges in biomarker integration, the diagnostic and prognostic value of pancreatic stone protein (PSP), and the role of point-of-care solutions such as the abioSCOPE® in advancing personalised...Read more

ICU Management

2025 24 Jul

Sepsis remains a leading cause of morbidity and mortality in intensive care units (ICUs), exacerbated by delays in diagnosis and inadequate risk stratification. Despite advances in critical care, conventional biomarkers like procalcitonin (PCT) and C-reactive protein (CRP) often fail to provide timely or specific detection. Pancreatic Stone Protein...Read more

ICU Management

2024 21 Apr

  Sepsis is a Medical Emergency Requiring Immediate Diagnosis & Treatment   Pancreatic Stone Protein (PSP) on the abioSCOPE® is the Earliest Marker of Sepsis   Sepsis is a major healthcare burden claiming more than 11 million lives per year, one death every 2.8 seconds 1 .   It is caused by a dysregulated host response to infection which...Read more

Sepsis

2024 21 Apr

  Sepsis is a Medical Emergency Requiring Immediate Diagnosis & Treatment   Pancreatic Stone Protein (PSP) on the abioSCOPE® is the Earliest Marker of Sepsis   Sepsis is a major healthcare burden claiming more than 11 million lives per year, one death every 2.8 seconds 1 .   It is caused by a dysregulated host response to infection which...Read more